Shire, the London-listed pharmaceuticals group, has moved to bolster its rare disease treatment business with the $4.2bn acquisition of ViroPharma. Ireland-domiciled Shire will pay $50 a share in cash ...

Uncomplicated skin infections account for almost 200 million physician-office visits in the USA annually. Treating these infections is estimated to cost in excess of US$350 million each year. The ...

Served as a speaker or a member of a speakers bureau for: F. Hoffmann-La Roche Ltd (Europe); Astellas Pharma, Inc. Received grants for clinical research from: Wyeth Pharmaceuticals Inc. Clinical ...